These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 19284778)

  • 1. Fragment-based discovery of nonpeptidic BACE-1 inhibitors using tethering.
    Yang W; Fucini RV; Fahr BT; Randal M; Lind KE; Lam MB; Lu W; Lu Y; Cary DR; Romanowski MJ; Colussi D; Pietrak B; Allison TJ; Munshi SK; Penny DM; Pham P; Sun J; Thomas AE; Wilkinson JM; Jacobs JW; McDowell RS; Ballinger MD
    Biochemistry; 2009 Jun; 48(21):4488-96. PubMed ID: 19284778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and X-ray crystallographic analysis of a spiropiperidine iminohydantoin inhibitor of beta-secretase.
    Barrow JC; Stauffer SR; Rittle KE; Ngo PL; Yang Z; Selnick HG; Graham SL; Munshi S; McGaughey GB; Holloway MK; Simon AJ; Price EA; Sankaranarayanan S; Colussi D; Tugusheva K; Lai MT; Espeseth AS; Xu M; Huang Q; Wolfe A; Pietrak B; Zuck P; Levorse DA; Hazuda D; Vacca JP
    J Med Chem; 2008 Oct; 51(20):6259-62. PubMed ID: 18811140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of fragment-based NMR screening, X-ray crystallography, structure-based design, and focused chemical library design to identify novel microM leads for the development of nM BACE-1 (beta-site APP cleaving enzyme 1) inhibitors.
    Wang YS; Strickland C; Voigt JH; Kennedy ME; Beyer BM; Senior MM; Smith EM; Nechuta TL; Madison VS; Czarniecki M; McKittrick BA; Stamford AW; Parker EM; Hunter JC; Greenlee WJ; Wyss DF
    J Med Chem; 2010 Feb; 53(3):942-50. PubMed ID: 20043700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyramine fragment binding to BACE-1.
    Kuglstatter A; Stahl M; Peters JU; Huber W; Stihle M; Schlatter D; Benz J; Ruf A; Roth D; Enderle T; Hennig M
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1304-7. PubMed ID: 18226904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel non-peptide inhibitors of BACE-1 using virtual high-throughput screening.
    Yi Mok N; Chadwick J; Kellett KA; Hooper NM; Johnson AP; Fishwick CW
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6770-4. PubMed ID: 19854048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of cyclic acylguanidines as highly potent and selective beta-site amyloid cleaving enzyme (BACE) inhibitors: Part I--inhibitor design and validation.
    Zhu Z; Sun ZY; Ye Y; Voigt J; Strickland C; Smith EM; Cumming J; Wang L; Wong J; Wang YS; Wyss DF; Chen X; Kuvelkar R; Kennedy ME; Favreau L; Parker E; McKittrick BA; Stamford A; Czarniecki M; Greenlee W; Hunter JC
    J Med Chem; 2010 Feb; 53(3):951-65. PubMed ID: 20043696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a novel warhead against beta-secretase through fragment-based lead generation.
    Geschwindner S; Olsson LL; Albert JS; Deinum J; Edwards PD; de Beer T; Folmer RH
    J Med Chem; 2007 Nov; 50(24):5903-11. PubMed ID: 17985861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining NMR and X-ray crystallography in fragment-based drug discovery: discovery of highly potent and selective BACE-1 inhibitors.
    Wyss DF; Wang YS; Eaton HL; Strickland C; Voigt JH; Zhu Z; Stamford AW
    Top Curr Chem; 2012; 317():83-114. PubMed ID: 21647837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress toward the discovery and development of efficacious BACE inhibitors.
    Durham TB; Shepherd TA
    Curr Opin Drug Discov Devel; 2006 Nov; 9(6):776-91. PubMed ID: 17117686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An inhibitor binding pocket distinct from the catalytic active site on human beta-APP cleaving enzyme.
    Kornacker MG; Lai Z; Witmer M; Ma J; Hendrick J; Lee VG; Riexinger DJ; Mapelli C; Metzler W; Copeland RA
    Biochemistry; 2005 Aug; 44(34):11567-73. PubMed ID: 16114893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of fragment screening by X-ray crystallography to beta-secretase.
    Murray CW; Callaghan O; Chessari G; Cleasby A; Congreve M; Frederickson M; Hartshorn MJ; McMenamin R; Patel S; Wallis N
    J Med Chem; 2007 Mar; 50(6):1116-23. PubMed ID: 17315856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Amino-3,4-dihydroquinazolines as inhibitors of BACE-1 (beta-site APP cleaving enzyme): Use of structure based design to convert a micromolar hit into a nanomolar lead.
    Baxter EW; Conway KA; Kennis L; Bischoff F; Mercken MH; Winter HL; Reynolds CH; Tounge BA; Luo C; Scott MK; Huang Y; Braeken M; Pieters SM; Berthelot DJ; Masure S; Bruinzeel WD; Jordan AD; Parker MH; Boyd RE; Qu J; Alexander RS; Brenneman DE; Reitz AB
    J Med Chem; 2007 Sep; 50(18):4261-4. PubMed ID: 17685503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of fragment screening by X-ray crystallography to the discovery of aminopyridines as inhibitors of beta-secretase.
    Congreve M; Aharony D; Albert J; Callaghan O; Campbell J; Carr RA; Chessari G; Cowan S; Edwards PD; Frederickson M; McMenamin R; Murray CW; Patel S; Wallis N
    J Med Chem; 2007 Mar; 50(6):1124-32. PubMed ID: 17315857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of oxadiazoyl tertiary carbinamine inhibitors of beta-secretase (BACE-1).
    Rajapakse HA; Nantermet PG; Selnick HG; Munshi S; McGaughey GB; Lindsley SR; Young MB; Lai MT; Espeseth AS; Shi XP; Colussi D; Pietrak B; Crouthamel MC; Tugusheva K; Huang Q; Xu M; Simon AJ; Kuo L; Hazuda DJ; Graham S; Vacca JP
    J Med Chem; 2006 Dec; 49(25):7270-3. PubMed ID: 17149856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent pyrrolidine- and piperidine-based BACE-1 inhibitors.
    Iserloh U; Wu Y; Cumming JN; Pan J; Wang LY; Stamford AW; Kennedy ME; Kuvelkar R; Chen X; Parker EM; Strickland C; Voigt J
    Bioorg Med Chem Lett; 2008 Jan; 18(1):414-7. PubMed ID: 18023580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apo and inhibitor complex structures of BACE (beta-secretase).
    Patel S; Vuillard L; Cleasby A; Murray CW; Yon J
    J Mol Biol; 2004 Oct; 343(2):407-16. PubMed ID: 15451669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease: identification and development of β-secretase (BACE-1) binding fragments and inhibitors by dynamic ligation screening (DLS).
    Fernández-Bachiller MI; Horatscheck A; Lisurek M; Rademann J
    ChemMedChem; 2013 Jul; 8(7):1041-56. PubMed ID: 23757181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of aminoheterocycles as a novel beta-secretase inhibitor class: pH dependence on binding activity part 1.
    Stachel SJ; Coburn CA; Rush D; Jones KL; Zhu H; Rajapakse H; Graham SL; Simon A; Katharine Holloway M; Allison TJ; Munshi SK; Espeseth AS; Zuck P; Colussi D; Wolfe A; Pietrak BL; Lai MT; Vacca JP
    Bioorg Med Chem Lett; 2009 Jun; 19(11):2977-80. PubMed ID: 19409780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From fragment screening to in vivo efficacy: optimization of a series of 2-aminoquinolines as potent inhibitors of beta-site amyloid precursor protein cleaving enzyme 1 (BACE1).
    Cheng Y; Judd TC; Bartberger MD; Brown J; Chen K; Fremeau RT; Hickman D; Hitchcock SA; Jordan B; Li V; Lopez P; Louie SW; Luo Y; Michelsen K; Nixey T; Powers TS; Rattan C; Sickmier EA; St Jean DJ; Wahl RC; Wen PH; Wood S
    J Med Chem; 2011 Aug; 54(16):5836-57. PubMed ID: 21707077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ensemble-docking approach on BACE-1: pharmacophore perception and guidelines for drug design.
    Limongelli V; Marinelli L; Cosconati S; Braun HA; Schmidt B; Novellino E
    ChemMedChem; 2007 May; 2(5):667-78. PubMed ID: 17407105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.